Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Option Care Health, Inc. | y88779e8vk.htm |
| EX-10.1 - EX-10.1 - Option Care Health, Inc. | y88779exv10w1.htm |
| EX-10.3 - EX-10.3 - Option Care Health, Inc. | y88779exv10w3.htm |
| EX-10.2 - EX-10.2 - Option Care Health, Inc. | y88779exv10w2.htm |
Exhibit 99.1
BioScrip Completes Debt Refinancing
ELMSFORD, N.Y., Dec 28, 2010 (BUSINESS WIRE) — BioScrip (NASDAQ: BIOS) today
announced it has closed a new $150.0 million syndicated revolving credit
facility.
“The new facility provides us with better terms and financial flexibility which
is an important first step in enabling us to reposition the Company and improve
profitability,” said Richard M. Smith, President and Chief Operating Officer of
BioScrip. “This new facility provides us with greater borrowing power to
support our future cash flow priorities.”
The new facility will be structured as an amendment and restatement of the
previous $100.0 million term loan and $50.0 million revolver. Healthcare
Finance Group, the collateral manager of its refinanced credit facilities will
be the primary lender and agent and will provide ongoing funding of eligible
accounts receivable and eligible inventory of BioScrip and its subsidiaries.
About BioScrip
BioScrip, Inc. (http://www.bioscrip.com) (Nasdaq: BIOS) is a national provider
of specialty pharmacy and home care products and services that partners with
patients, physicians, hospitals, healthcare payors and pharmaceutical
manufacturers to provide clinical management solutions and delivery of
cost-effective access to prescription medications. Our services are designed to
improve clinical outcomes for chronic and acute healthcare conditions while
controlling overall healthcare costs.
Forward Looking Statements-Safe Harbor
Statements contained in this press release that express a belief, expectation,
anticipation or intent are considered forward-looking statements and are
protected under the Safe Harbor of Private Securities Litigation and Reform
Act. These forward-looking statements are based on information available to the
Company today, and the Company assumes no obligation to update statements as
circumstances change. These forward-looking statements may involve a number of
risks and uncertainties, which may cause the Company’s results to differ
materially from such statements.
Forward-looking statements are subject to inherent risks and uncertainties
surrounding future expectations generally and may differ materially from actual
future experience. Risks and uncertainties that could affect forward-looking
statements include the failure to realize synergies as a result of operational
efficiencies or revenue opportunities, the failure to successfully integrate
the business and operations from the CHS acquisition, leverage core
competencies or maximize margins and operating cash flow generation, and the
risks described from time to time in the Company’s reports filed with the SEC,
including the Company’s annual report on Form 10-K for the year ended December
31, 2009 and the Company’s quarterly reports on Form 10-Q for the quarters
ended March 31, 2010 and June 30, 2010.
SOURCE: BioScrip, Inc.
Joele Frank, Wilkinson Brimmer Katcher
Dan Katcher / Bryan Darrow, 212-355-4449
Dan Katcher / Bryan Darrow, 212-355-4449